Agenda

All times displayed for Asia/Bangkok timezone.

Cannabis and Herbal Health Products; Turn Chaos to Opportunities
09:00 - 16:00 Podium 1 - Challenger Hall 2
Conference

Addmision fee : Early Bird (15th Feb. 2020)
Member 1,500.00 THB
General 1,750.00 THB
After May 2020
Member 1,750.00 THB
General 2,000.00 THB

Registration: https://www.pat.or.th/index.php/component/content/article/92-2017-10-01-...

For more information: https://www.pat.or.th/
Morning Session
09:00 - 09:15 Update on Cannabis for Medical and other applications in Thailand
09:15 - 10:00 Challenges in Creating Standards for Quality Control of Cannabis Derived Products
10:00 - 10:45 Critical Issues—Spotlight on Quality Control and Analytical Testing Standards for the Medicinal Cannabis Industry
10:45 - 11:00 Break
11:00 - 12:00 Enhancing the Bioavailability of Cannabinoids in Pharmaceutical Dosage Forms
12:00 - 13:30 Lunch
Afternoon session Act of legislation (herbal product)
13:30 - 14:15 Updating on the Herbal Products Act B.E. 2562 and registration process of Herbal Products
14:15 - 15:00 Policies and principle to promote the development of herbal products in Thailand
15:00 - 15:15 Break
15:15 - 16:45 Panel discussion : creating a pathway for Thai hergal go global
16:45 - 17:00 Conclusion

Pharmaceutical and Chemical Industry Risk Management
09:00 - 16:00 Podium 1 - Challenger Hall 2
Conference

08.00 - 09.00 Registration
09.00 - 10.15 Hazard Identification
10.15 - 10.30 Break
10.30 - 12.00 Hazard Identification
12.00 - 13.00 Lunch
13.00 - 14.15 Risk Assessment
14.15 - 14.30 Break
14.30 - 16.00 Risk Treatment Plan

VIRUS 2020
09:00 - 12:00 Podium 3 - Challenger Hall 2
Conference
Therapeutic Effect of Gymnema Inodorum (Lour.) Decne. Extract on Diabetes Mellitus
10:15 - 10:45 Health Theatre
Health Theatre
Natural Products, Dietary Supplements & Traditional Medicines: Business Development Strategies to unlock the opportunities.
10:15 - 10:45 Technical seminar room
Technical seminar
R.Ph Strategic Pharma Business Development Consultant & Market Research Pharmacist
Pharma Synergies

SEA Pharmaceutical Market Size is expected to be > US$ 40 Bn by 2021 with a
growth rate of > 9% since 2016, which is one of the highest growths in the world.
It presents significant opportunity to ‘Natural Products, Dietary Supplements and Traditional Medicines’. It can be estimated that the market for these alternate & complimentary medicines can be additional ? 15 Bn with similar growth rate.
The rich heritage of traditional medicines, demographics like 655 million population, growing healthcare costs, the regional governments adopting ‘Universal Healthcare Policy of affordability and easy access’ present significant opportunity. The emerging opportunities like preference for natural and safe consumer & personal healthcare products are the drivers. This presentation will be useful to all the concerned stakeholders esp. Startups and SMEs to understand about sustainable business models, easy-to-implement & cost-effective business development strategies to avail of the opportunities, while managing the challenges.
Case Studies will be discussed.

Purification of gene therapy products with monoliths.
11:00 - 11:30 Technical seminar room
Technical seminar
Chief Scientific Officer at BIA Separations, BIA Separations d.o.o. (Slovenia)
Applied Chemical and Instrument Co.,Ltd. (ACI)

Company intro:
BIA Separations specializes in chromatographic purification of the most challenging biomolecules. The ability of a purification process to deal with big vulnerable molecules and stubborn impurities, for example, hcDNA, is a distinctive advantage. BIA’s downstream platforms are based on unique monolithic chromatographic media, namely, CIM® monolithic columns, distinguished for their flow independent performance, resulting in fast separation, concentration, purification and analytics. Elaborate column design reduces shear stress that vulnerable molecules are subjected to, thus significantly increases final recovery. Cutting-edge applications focus on downstream processing of exosomes, viruses (AAV, Influenza, etc.), plasmid DNA, bacteriophages and mRNA. We provide products that range from small analytical columns to large industrial prep-scale columns (including cGMP and disposable units in IEX, HIC, affinity and customized formats). As such, our products are used in research, laboratory, pilot and industrial production stages and are extremely simple to use, with no packing of columns needed.
Lecturers Bio:
Pete Gagnon is a widely respected global authority in the field of downstream processing. He is the author or more than 100 scientific publications and inventor on more than 100 awarded patents in the United States, Europe, and Asia. His expertise covers purification of monoclonal antibodies, virus particles, extra-cellular vesicles, plasmid DNA, and mRNA. He is currently Chief Scientific Officer at BIA Separations, a European manufacturer of specialized chromatography media for purification of gene therapy products.

Improvement Bioavailability with Lonza Engine – Micronization.
11:45 - 12:45 Technical seminar room
Technical seminar
Evaluation of Anti-Hypertensive Potential of Natural Extracts
13:30 - 14:00 Health Theatre
Health Theatre
Seminar from TPMA
13:30 - 16:00 Podium 3 - Challenger Hall 2
Conference
ANNEX 1
13:30 - 14:45 Technical seminar room
Technical seminar
President and CEO, Parenteral Drug Association, Washington DC
Parenteral Drug Association® (PDA)

WHAT TO EXPECT FROM ANNEX 1 & QUALITY RISK MANAGEMENT

Health Theatre
14:15 - 14:45 Health Theatre
Health Theatre